Sign up to save your podcasts
Or
Share Realizing the Full Potential of CRISPR: Is the Hype Getting in the Way of Progress?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Realizing the Full Potential of CRISPR: Is the Hype Getting in the Way of Progress?
Clinical applications of CRISPR have matured very fast, promising to deliver precise gene therapy solutions to inherited genetic conditions and new approaches to cancer treatment. But the path to new CRISPR-based cures won’t be smooth sailing. Rachel Haurwitz, President, CEO, and Co-Founder of Caribou Biosciences discusses this technology and the biggest roadblocks to CRISPR-based therapies.
View all episodes
By DIA
5
33 ratings
Clinical applications of CRISPR have matured very fast, promising to deliver precise gene therapy solutions to inherited genetic conditions and new approaches to cancer treatment. But the path to new CRISPR-based cures won’t be smooth sailing. Rachel Haurwitz, President, CEO, and Co-Founder of Caribou Biosciences discusses this technology and the biggest roadblocks to CRISPR-based therapies.